Center for Scientific Review; Notice of Closed Meetings, 8488-8489 [2018-03870]
Download as PDF
<![CDATA[
8488
Federal Register / Vol. 83, No. 39 / Tuesday, February 27, 2018 / Notices
Academy of Medicine (NAM). Since
then, there have been advancements in
science and gaps identified in the
existing guidelines, including a greater
emphasis on practice-based clinical
considerations. To address these, HRSA
awarded a 5-year cooperative agreement
in March 2016 to convene a coalition of
clinician, academic and consumerfocused health professional
organizations and conduct a
scientifically rigorous review to develop
recommendations for updated Women’s
Preventive Services Guidelines in
accordance with the model created by
the NAM Clinical Practice Guidelines
We Can Trust. The American College of
Obstetricians and Gynecologists was
awarded the cooperative agreement and
formed an expert panel called the
Women’s Preventive Services Initiative.
Under section 2713 of the Public
Health Service Act, non-grandfathered
group health plans and issuers of nongrandfathered group and individual
health insurance coverage are required
to cover specified preventive services
without a copayment, coinsurance,
deductible, or other cost sharing,
including preventive care and
screenings for women as provided for in
comprehensive guidelines supported by
HRSA for this purpose. Nongrandfathered group health plans and
health insurance issuers offering nongrandfathered group or individual
coverage (generally, plans or policies
created or sold after March 23, 2010, or
older plans or policies that have been
changed in certain ways since that date)
are required to provide coverage
without cost sharing for preventive
services listed in the updated HRSAsupported guidelines (which include
the nine preventive services set out in
the 2016 update, as well as the two
services added in this update) beginning
with the first plan year (in the
individual market, policy year) that
begins on or after December 29, 2018.
Dated: February 20, 2018.
George Sigounas,
Administrator.
[FR Doc. 2018–03840 Filed 2–26–18; 8:45 am]
BILLING CODE 4165–15–P
daltland on DSKBBV9HB2PROD with NOTICES
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
VerDate Sep<11>2014
19:49 Feb 26, 2018
Jkt 244001
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
366 Dual Purpose with Dual Benefit:
Research in Biomedicine and Agriculture.
Date: March 21–22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Tera Bounds, DVM, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214,
MSC 7808, Bethesda, MD 20892, 301–435–
2306, boundst@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict.
Date: March 21, 2018.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kate Fothergill, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3142,
Bethesda, MD 20892, 301–435–2309,
fothergillke@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: The Biostatistical Methods and
Research Design.
Date: March 21, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Ping Wu, Ph.D., Scientific
Review Officer, HDM IRG, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3166,
Bethesda, MD 20892, 301–451–8428, wup4@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
AIDS and Related Research.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW, Washington, DC 20037.
Contact Person: Robert Freund, Ph.D.,
Scientific Review Officer, Center for
PO 00000
Frm 00071
Fmt 4703
Sfmt 4703
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5216,
MSC 7852, Bethesda, MD 20892, 301–435–
1050, freundr@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Fellowship:
Infectious Diseases and Microbiology.
Date: March 22–23, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Embassy Suites DC Convention
Center, 900 10th Street NW, Washington, DC
20001.
Contact Person: Tamara Lyn McNealy,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3188,
Bethesda, MD 20747, 301–827–2372,
tamara.mcnealy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Cancer Health Disparities.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hyatt Regency Bethesda, One
Bethesda Metro Center, 7400 Wisconsin
Avenue, Bethesda, MD 20814.
Contact Person: Janet M. Larkin, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142,
MSC 7840, Bethesda, MD 20892, 301–806–
2765, larkinja@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Innovative Immunology.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: The William F. Bolger Center, 9600
Newbridge Drive, Potomac, MD 20854.
Contact Person: Andrea Keane-Myers,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218,
Bethesda, MD 20892, 301–435–1221,
andrea.keane-myers@nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; AIDS
Discovery and Development of Therapeutics
Study Section.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW, Washington, DC 20037.
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group;
NeuroAIDS and other End-Organ Diseases
Study Section.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
E:\FR\FM\27FEN1.SGM
27FEN1
daltland on DSKBBV9HB2PROD with NOTICES
Federal Register / Vol. 83, No. 39 / Tuesday, February 27, 2018 / Notices
Place: The Fairmont Washington, DC, 2401
M Street NW, Washington, DC 20037.
Contact Person: Eduardo A. Montalvo,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108,
MSC 7852, Bethesda, MD 20892, (301) 435–
1168, montalve@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Undiagnosed Diseases Review.
Date: March 22–23, 2018.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Katherine M. Malinda,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140,
MSC 7814, Bethesda, MD 20892, 301–435–
0912, Katherine_Malinda@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection, and
Bioremediation.
Date: March 22–23, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Rockville, MD 20852.
Contact Person: Gagan Pandya, Ph.D.,
Scientific Review Officer, National Institutes
of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808,
Bethesda, MD 20892, 301–435–1167,
pandyaga@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR–16–
262: Sustained Release of Antivirals for
Treatment or Prevention of HIV.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: The Fairmont Washington, DC, 2401
M Street NW, Washington, DC 20037.
Contact Person: Shiv A. Prasad, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220,
MSC 7852, Bethesda, MD 20892, 301–443–
5779, prasads@csr.nih.gov.
Name of Committee: AIDS and Related
Research Integrated Review Group; HIV/
AIDS Vaccines Study Section.
Date: March 22, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Residence Inn Bethesda, 7335
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Barna Dey, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3184,
Bethesda, MD 20892, 301–435–0000, bdey@
mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
VerDate Sep<11>2014
19:49 Feb 26, 2018
Jkt 244001
Conflicts and PAR: Biobehavioral
Applications on Substance Abuse and
Decision-Making.
Date: March 22, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Andrea B. Kelly, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182,
MSC 7770, Bethesda, MD 20892, (301) 455–
1761, kellya2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Translational Research in Pediatric and
Obstetric Pharmacology and Therapeutics.
Date: March 22, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6175,
MSC 7892, Bethesda, MD 20892, 301–435–
1154, dianne.hardy@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; BRAIN
Initiative: Targeted BRAIN Circuits Projects.
Date: March 22, 2018.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5184,
MSC 7844, Bethesda, MD 20892, 301–435–
1242, kgt@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Neurological Disorders.
Date: March 22, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Laurent Taupenot, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188,
MSC 7850, Bethesda, MD 20892, 301–435–
1203, laurent.taupenot@nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Cellular and Molecular
Immunology.
Date: March 22, 2018.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
PO 00000
Frm 00072
Fmt 4703
Sfmt 4703
8489
Contact Person: Tina McIntyre, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4202,
MSC 7812, Bethesda, MD 20892, 301–594–
6375, mcintyrt@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR:
Electronic Nicotine Delivery Systems
(ENDS): Population, Clinical and Applied
Prevention Research.
Date: March 22, 2018.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Miriam Mintzer, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108,
Bethesda, MD 20892, 301–523–0646,
mintzermz@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: February 21, 2018.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2018–03870 Filed 2–26–18; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of
Meeting
Pursuant to section 10(a) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the National Cancer Institute
Board of Scientific Advisors.
The meeting will be open to the
public, with attendance limited to space
available. Individuals who plan to
attend and need special assistance, such
as sign language interpretation or other
reasonable accommodations, should
notify the Contact Person listed below
in advance of the meeting. The meeting
will also be videocast and can be
accessed from the NIH Videocasting and
Podcasting website (https://
videocast.nih.gov/).
Name of Committee: National Cancer
Institute Board of Scientific Advisors.
Date: March 20, 2018.
Time: 8:30 a.m. to 5:00 p.m.
Agenda: Director’s Report: Ongoing and
New Business; RFA and RFP Concept
Reviews; and Scientific Presentations.
Place: National Cancer Institute—Shady
Grove, 9609 Medical Center Drive, Room
TE406, Rockville, MD 20850.
E:\FR\FM\27FEN1.SGM
27FEN1
]]>Agencies
[Federal Register Volume 83, Number 39 (Tuesday, February 27, 2018)]
[Notices]
[Pages 8488-8489]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2018-03870]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-366 Dual Purpose with Dual Benefit: Research in
Biomedicine and Agriculture.
Date: March 21-22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Tera Bounds, DVM, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3214, MSC 7808, Bethesda, MD
20892, 301-435-2306, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict.
Date: March 21, 2018.
Time: 11:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kate Fothergill, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3142, Bethesda, MD 20892, 301-
435-2309, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: The Biostatistical Methods and Research
Design.
Date: March 21, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Ping Wu, Ph.D., Scientific Review Officer, HDM
IRG, Center for Scientific Review, National Institutes of Health,
6701 Rockledge Drive, Room 3166, Bethesda, MD 20892, 301-451-8428,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: AIDS and Related Research.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW,
Washington, DC 20037.
Contact Person: Robert Freund, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5216, MSC 7852, Bethesda, MD 20892, 301-435-
1050, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Fellowship: Infectious Diseases and Microbiology.
Date: March 22-23, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Embassy Suites DC Convention Center, 900 10th Street NW,
Washington, DC 20001.
Contact Person: Tamara Lyn McNealy, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3188, Bethesda, MD 20747, 301-
827-2372, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Cancer Health Disparities.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400
Wisconsin Avenue, Bethesda, MD 20814.
Contact Person: Janet M. Larkin, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5142, MSC 7840, Bethesda, MD
20892, 301-806-2765, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Innovative Immunology.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: The William F. Bolger Center, 9600 Newbridge Drive,
Potomac, MD 20854.
Contact Person: Andrea Keane-Myers, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4218, Bethesda, MD 20892, 301-
435-1221, [email protected].
Name of Committee: AIDS and Related Research Integrated Review
Group; AIDS Discovery and Development of Therapeutics Study Section.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW,
Washington, DC 20037.
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, 301-443-5779, [email protected].
Name of Committee: AIDS and Related Research Integrated Review
Group; NeuroAIDS and other End-Organ Diseases Study Section.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
[[Page 8489]]
Place: The Fairmont Washington, DC, 2401 M Street NW,
Washington, DC 20037.
Contact Person: Eduardo A. Montalvo, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5108, MSC 7852, Bethesda, MD
20892, (301) 435-1168, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Undiagnosed Diseases Review.
Date: March 22-23, 2018.
Time: 8:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Katherine M. Malinda, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4140, MSC 7814, Bethesda, MD
20892, 301-435-0912, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Small Business: Non-HIV Diagnostics, Food Safety,
Sterilization/Disinfection, and Bioremediation.
Date: March 22-23, 2018.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Rockville, MD 20852.
Contact Person: Gagan Pandya, Ph.D., Scientific Review Officer,
National Institutes of Health, Center for Scientific Review, 6701
Rockledge Drive, RM 3200, MSC 7808, Bethesda, MD 20892, 301-435-
1167, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR-16-262: Sustained Release of Antivirals for Treatment or
Prevention of HIV.
Date: March 22, 2018.
Time: 8:00 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant applications.
Place: The Fairmont Washington, DC, 2401 M Street NW,
Washington, DC 20037.
Contact Person: Shiv A. Prasad, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5220, MSC 7852, Bethesda, MD
20892, 301-443-5779, [email protected].
Name of Committee: AIDS and Related Research Integrated Review
Group; HIV/AIDS Vaccines Study Section.
Date: March 22, 2018.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Residence Inn Bethesda, 7335 Wisconsin Avenue, Bethesda,
MD 20814.
Contact Person: Barna Dey, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 3184, Bethesda, MD 20892, 301-435-0000,
[email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflicts and PAR: Biobehavioral Applications on
Substance Abuse and Decision-Making.
Date: March 22, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Andrea B. Kelly, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3182, MSC 7770, Bethesda, MD
20892, (301) 455-1761, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Translational Research in Pediatric and Obstetric
Pharmacology and Therapeutics.
Date: March 22, 2018.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Dianne Hardy, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 6175, MSC 7892, Bethesda, MD 20892, 301-435-
1154, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; BRAIN Initiative: Targeted BRAIN Circuits Projects.
Date: March 22, 2018.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kirk Thompson, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5184, MSC 7844, Bethesda, MD 20892, 301-435-
1242, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Neurological Disorders.
Date: March 22, 2018.
Time: 1:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Laurent Taupenot, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4188, MSC 7850, Bethesda, MD
20892, 301-435-1203, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; Member Conflict: Cellular and Molecular Immunology.
Date: March 22, 2018.
Time: 3:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Tina McIntyre, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 4202, MSC 7812, Bethesda, MD 20892, 301-594-
6375, [email protected].
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR: Electronic Nicotine Delivery Systems (ENDS): Population,
Clinical and Applied Prevention Research.
Date: March 22, 2018.
Time: 12:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892.
Contact Person: Miriam Mintzer, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3108, Bethesda, MD 20892, 301-
523-0646, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: February 21, 2018.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2018-03870 Filed 2-26-18; 8:45 am]
BILLING CODE 4140-01-P
